Medical News

RSS

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment.

From BD (Becton, Dickinson and Company) 10 Feb 2011

APS announces new online public access initiative for US high schools

The American Physical Society announces a new public access initiative that will give high school students and teachers in the United States full use of all online APS journals, from the most recent articles back to the first issue in 1893, a collection including over 400,000 scientific research papers.

10 Feb 2011

FDA proposes plan to speed medical device reviews

The approach, which would focus on first-of-a-kind devices with the potential to make a significant difference for patients, could cut in half the current amount of time spent reviewing most new devices.

10 Feb 2011

BG Medicine underwriters exercise over-allotment option in full

BG Medicine today announced that the underwriters of its initial public offering have exercised in full their over-allotment option to purchase an additional 750,000 shares of BG Medicine's common stock at $7.00 per share, less underwriting discounts and commissions.

10 Feb 2011

New research: Motorcycle helmets appear to reduce cervical spine injury

Motorcycle helmets, long known to dramatically reduce the number of brain injuries and deaths from crashes, appear to also be associated with a lower risk of cervical spine injury, new research from Johns Hopkins suggests.

10 Feb 2011

BioSan announces precautionary voluntary recall over undeclared soy in Essentials, RightFoods products

BioSan Laboratories announced today a recall of products in its Essentials™ and RightFoods™ lines because they may contain undeclared soy. BioSan Laboratories has not received any reports of adverse or allergic reactions to these products. Although the levels of soy are low, people with soy allergies risk an allergic reaction if they consume these products.

10 Feb 2011

Myriad Genetics' 46-gene PROLARIS molecular diagnostic test predicts prostate cancer outcome

Myriad Genetics, Inc. announced today that a study published in Lancet Oncology shows the Company's 46-gene PROLARIS™ molecular diagnostic test significantly predicts prostate cancer outcome.

10 Feb 2011

House Republicans push anti-abortion bills

Two bills have been introduced in the House but Senate Democrats vow to stop their progress if they clear the lower chamber.

10 Feb 2011

New low-cost Medicare Supplement insurance policy is now available for Georgia seniors

A new low-cost Medicare Supplement insurance policy is now approved for sale to seniors in Georgia. The Georgia Office of Insurance and Safety Fire Commission has approved a very low-cost Medicare Supplement insurance plan for seniors and Georgia is among the first states in the nation to allow this supplemental insurance plan to be offered to its citizens.

10 Feb 2011

OraSure registers $3.5 million net loss for full year 2010

OraSure Technologies, Inc., a market leader in oral fluid diagnostics, today announced revenues of $75.0 million and $18.8 million for the year and quarter ended December 31, 2010, respectively. This compares to revenues of $77.0 million and $20.9 million for the year and quarter ended December 31, 2009.

10 Feb 2011

E-cigarettes produce abstinence rates nearly double that of traditional method

Two new studies available online and being published in the April edition of the American Journal of Preventative Medicine find that electronic cigarettes produces abstinence rates nearly double that of traditional nicotine replacement methods and that consumer interest in e-cigarettes is currently much higher than interest in traditional nicotine replacement products.

10 Feb 2011

Study: Drug-eluting stents outperform BMS for revascularization of CTOs

A systematic review of medical evidence has determined drug-eluting stents outperform bare metal stents for revascularization of chronic total occlusions.

10 Feb 2011

GOP advances plan to block health law funding

Under the House Republicans' plan, language to block money for the overhaul implementation would be attached as an amendment to a stop-gap spending bill necessary to finance the federal government for the rest of the year.

10 Feb 2011

Study: New curcumin-hybrid compound may help protect, regenerate brain cells after stroke

Whether or not you're fond of Indian, Southeast Asian and Middle Eastern food, stroke researchers at Cedars-Sinai Medical Center think you may become a fan of one of their key spices.

10 Feb 2011

Opinions: Polio vaccines; Alternatives to DDT, insecticides; Food price volatility; Global poverty; Foreign aid for vaccines

"No one denies" that the oral polio vaccine "has considerable merits. It's cheap to make. It's easy to administer; you don't need a trained nurse with a clean syringe [like the inactive vaccine needs], just a volunteer with a dropper. And it gives excellent immunity. ... But there are problems with the method," Wendy Orent, author of the book Plague: The Mysterious Past and Terrifying Future of the World's Most Dangerous Disease, writes in a Los Angeles Times opinion piece.

10 Feb 2011

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

Neuralstem, Inc. announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted it orphan drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS) with its human spinal cord derived neural stem cells (NSI-566RSC), currently in a Phase I safety study to evaluate the safety of the product and the surgical route of administration in a wide range of ALS patients.

10 Feb 2011

Teva reports positive results from QNAZE Phase III perennial allergic rhinitis trial

Teva Pharmaceutical Industries Ltd. today announced results from a Phase III study of QNAZE™ (beclomethasone dipropionate [BDP]) HFA, its nasal aerosol corticosteroid in development for the treatment of perennial allergic rhinitis (PAR) and seasonal allergic rhinitis (SAR).

10 Feb 2011

Cephalon to acquire Alba Therapeutics

Cephalon, Inc. and Alba Therapeutics Corporation, a privately held biopharmaceutical company, today announced that the companies have signed an agreement providing Cephalon with an option to purchase all of Alba's assets relating to larazotide acetate, a tight junction modulator, progressing toward a Phase IIb clinical trial for the treatment of celiac disease.

10 Feb 2011

New study: Fetal surgery for spina bifida greatly improves child's mobility

Performing delicate surgery in the womb, months before birth, can substantially improve outcomes for children with a common, disabling birth defect of the spine. Experts at The Children's Hospital of Philadelphia co-led a new landmark study showing that fetal surgery for spina bifida greatly reduces the need to divert fluid from the brain, improves mobility and improves the chances that a child will be able to walk independently.

9 Feb 2011

People with memory problems may face high risk of stroke

People who have memory problems or other declines in their mental abilities may be at higher risk for stroke, according to a study released today that will be presented at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011.

9 Feb 2011

Medical News

BD and UCLB enter agreement for development of new diagnostics for ovarian, breast cancer

APS announces new online public access initiative for US high schools

FDA proposes plan to speed medical device reviews

BG Medicine underwriters exercise over-allotment option in full

New research: Motorcycle helmets appear to reduce cervical spine injury

BioSan announces precautionary voluntary recall over undeclared soy in Essentials, RightFoods products

Myriad Genetics' 46-gene PROLARIS molecular diagnostic test predicts prostate cancer outcome

House Republicans push anti-abortion bills

New low-cost Medicare Supplement insurance policy is now available for Georgia seniors

OraSure registers $3.5 million net loss for full year 2010

E-cigarettes produce abstinence rates nearly double that of traditional method

Study: Drug-eluting stents outperform BMS for revascularization of CTOs

GOP advances plan to block health law funding

Study: New curcumin-hybrid compound may help protect, regenerate brain cells after stroke

Opinions: Polio vaccines; Alternatives to DDT, insecticides; Food price volatility; Global poverty; Foreign aid for vaccines

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

Teva reports positive results from QNAZE Phase III perennial allergic rhinitis trial

Cephalon to acquire Alba Therapeutics

New study: Fetal surgery for spina bifida greatly improves child's mobility

People with memory problems may face high risk of stroke

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News